SARS-CoV-2 can directly activate the complement system via all three complement pathways [31], and single-nucleotide variants of complement C4BP-α, which interacts with PROS1 [23], are risk factors for morbidity and death in COVID-19 [32]. This evidence concerns the gene PROS1 and COVID-19.